SNWV vs. MDXG, ESTA, PLSE, BLFS, INMD, IRMD, TNDM, KMTS, SIBN, and BBNX
Should you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include MiMedx Group (MDXG), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), SiBone (SIBN), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.
Sanuwave Health vs. Its Competitors
Sanuwave Health (NASDAQ:SNWV) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.
42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by company insiders. Comparatively, 1.7% of MiMedx Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Sanuwave Health has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.
MiMedx Group has a net margin of 8.84% compared to Sanuwave Health's net margin of -97.03%. MiMedx Group's return on equity of 23.03% beat Sanuwave Health's return on equity.
In the previous week, MiMedx Group had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for MiMedx Group and 1 mentions for Sanuwave Health. MiMedx Group's average media sentiment score of 1.71 beat Sanuwave Health's score of 1.05 indicating that MiMedx Group is being referred to more favorably in the news media.
Sanuwave Health presently has a consensus price target of $49.00, indicating a potential upside of 27.74%. MiMedx Group has a consensus price target of $12.00, indicating a potential upside of 66.90%. Given MiMedx Group's higher probable upside, analysts clearly believe MiMedx Group is more favorable than Sanuwave Health.
MiMedx Group has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.
Summary
MiMedx Group beats Sanuwave Health on 12 of the 14 factors compared between the two stocks.
Get Sanuwave Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sanuwave Health Competitors List
Related Companies and Tools
This page (NASDAQ:SNWV) was last updated on 8/18/2025 by MarketBeat.com Staff
MarketBeat All Access